Ricerca mobile Health

Qualità dei dati a livello accademico

In collaborazione con i centri di ricerca sul cancro, gli ospedali e il settore delle scienze della vita, siamo impegnati nell’empowerment dei pazienti (partecipazione e codecisione nel settore sanitario) e nella raccolta di dati a livello di studi regolatori. I sintomi registrati dai pazienti in combinazione con i dati clinici aprono nuove prospettive e opportunità per l’assistenza medica e la ricerca (prove reali).

Più di 1000 pazienti sono già collegati al nostro sistema.

Ciò consentirà lo sviluppo di nuovi metodi mirati per il trattamento del cancro e delle malattie.

MobileHealth-Network-Parts_Patient

In qualità di pazienti

Sostenete la ricerca sul cancro condividendo i vostri dati nell’app in forma pseudonimizzata. In questo modo, contribuite a migliorare le cure con la vostra esperienza di pazienti, naturalmente su base volontaria.

MobileHealth-Network-Parts-Arzt

Come medico

Sostenete la ricerca sul cancro aiutando i vostri pazienti a utilizzare l’applicazione e partecipando a studi e registri di eHealth.

MobileHealth-Network-Parts-Hospital

Co-creazione

Avviare insieme nuovi approcci di ricerca: avete un’idea? Abbiamo gli strumenti, i contatti e l’esperienza necessari.

Studies and Publications

      • Proprietary Consilium Care Platform & App

    CE-Mark Class I (MDD Class I)

    Enables symptom progression tracking and CTCAE-based notifications to patients and oncologists.

        • Clinical Trial: Patient-App Improves Daily Activity

      Randomized trial in 140 breast cancer patients undergoing chemotherapy

      📰 Published in JMIR 2016

      🔗 PubMed: 27601354

          • Collaboration with SAKK – Alpine Tumor Immunology Registry (TIR)

        Symptom recording in 150 patients undergoing immunotherapy

        📰 SAKK Trial Link

        ✔️ Accepted for publication in Current Oncology

        (Topic: machine learning on ePROs to cluster symptoms by cancer type)

            • Consilium App Improves ePRO Monitoring in Immunotherapy

          Case report in lung cancer: shared reporting improves comfort and efficiency

          📰 Case Reports in Oncology, 2020

          🔗 PubMed: 32518544

              • Clinical Trial: Patient-App Improves Symptom Recording

            Digital symptom recording enhances patient-doctor interaction in 192 cancer patients

            📰 JMIR Cancer, 2021

            🔗 PubMed: 33729162

                • Report on Medication Effectiveness in Personalized Medicine

              Durable response and tolerability in breast cancer therapy

              📰 Case Reports in Oncology, 2021

              🔗 PubMed: 32518544

                  • Review: ePROs Improve Congruence of Patient- and Clinician-Reported Toxicity

                Collaborative monitoring in 224 cancer patients

                📰 JMIR, 2021

                🔗 PubMed: 33729162

                    • HER2-Biosimilar in Breast Cancer (OGIPRO Study)

                  Real-world ePRO observational trial – 80 patients, 8 centers

                  📰 Published in JMIR Cancer (2024)

                  🔗 Article

                  🔍 kofam Trial Registry


                  Ongoing Trials and Registries

                      • THC-CBD for Nausea, Emesis, Sleeplessness, Pain, Anxiety, Appetite Loss in Cancer Assessed via ePRO

                    Prospective randomized controlled study – 150 patients, 6 centers

                    Registry now maintained under Swiss sponsorship

                    🔗 FMH Medical Registry

                        • Efficiency of the “Medidux” Smartphone App for Demission Management in Patients Medicated in Acute Admission Unit (AAU)

                      Observational study on emergency-related symptom tracking and cost reduction

                      🔗 ClinicalTrials.gov: NCT06655337

                        • Evaluation of the Positive Care Effect of the Digital Health App Consilium Care Oncology

                       

                      Multicenter randomized controlled trial with 520 patients, 40 centers (Germany & Switzerland)

                       

                      🧪 Ongoing trial

                       

                      Ethics Approval: KEK-2022-D0021

                      Prof. Dr. med. Andreas Trojan

                      CEO, Chief Medical Officer, Founder

                      Team and expertise

                      Products developed by qualified experts

                      Andreas holds a position as senior oncologist at both, the Brust- and the OnkoZentrum Zürich in Switzerland. Moreover, he is a titular-professor at the medical faculty of the University of Zurich. Treating cancer patients over more than 20 years clearly indicated that the consideration of PROs is key for treatment success. Driven by this conviction Andreas founded Mobile Health AG and started to develop Consilium Care™, an App for patients to capture well-being and therapy side effects. The current large observational study, started in 2018, investigates the efficiency of the “Consilium Care™” smartphone App for detecting symptoms and treatment side effects in cancer patients depending on form of medication application, age and outpatient characteristics.

                      Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

                      Individual patient

                      Doctor

                      Consilium Care™ platform

                      1. Patients track their health with Consilium Care™

                      Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation.

                      3. Treatment plans can be adjusted due to insights

                      Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation.

                      Mobile Health

                      Evidence-based care in the real-world

                      Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.